Covid-19 vaccines offer ‘high levels’ of protection for immunosuppressed

The Pfizer coronavirus vaccine (PA)

Covid-19 vaccines offer high levels of protection for most people with underlying health conditions or who are immunosuppressed, Public Health England (PHE) has said.

New data from more than one million people in at-risk groups found that overall vaccine effectiveness against symptomatic disease was around 60% after one dose of either the AstraZeneca or Pfizer/BioNTech jabs, and did not fall substantially with age.